Total Credits: 1.5 including 1.5 AOA Category 1-A Credit(s)
Learning Objectives:
Be aware of state requirements in prescribing controlled substances
Understand who is a pain physician and what defines a pain clinic
Be aware of penalties associated with failure to comply with state laws
Understand how federal regulations interact with state ones and impact your practice.
Accreditation Statement for DOCME programs:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Mississippi Osteopathic Medical Association (MOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Disclosure:
Dr. Bailey has no actual or potential conflict of interest in relation to this program or presentation.
Grievance Statement:
All grievances may be directed to MOMA's Executive Director at info@moma-net.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| prescribing controlled Substances (8.8 MB) | 57 Pages | Available after Purchase |
J. Mark Bailey, DO, PhD is a native Mississippian who attended Millsaps College as an undergraduate and the University of MS Medical Center for his PhD in Anatomy. He attended the College of Osteopathic Medicine of the Pacific in Pomona California and afterwards relocated to Birmingham Alabama for internship and residency. Dr. Bailey was in private practice for 13 years and is now Professor of Neurology and Anesthesiology at the University of Alabama at Birmingham (UAB). He is board certified in both Neurology and Pain. Dr. Bailey is a past president of the Alabama Osteopathic Medical Association. He is President-elect and a fellow of the American College of Osteopathic Neurologists and Psychiatrists. Dr. Bailey participated in the creation of the Osteopathic Pain Medicine Boards and serves as the AOA advisor to the AMA CPT committee. He is the AOA representative to the Federation of State Medical Boards Opioid Task Force as well as the American Academy of Neurology representative to the AMA Opioid Task Force.